wada aod9604 prohibited list status 2025 just added tirzepatide (mounjaro) to the 2026 Monitoring Program WADA published 2025 Prohibited List
Description
Materials needed Your 5-Amino-1MQ vial (lyophilized) Alcohol swabs Bacteriostatic sterile water 3 mL syringes (Luer Lock tip) 25G or 27G needles (Luer Lock)
GLP-1 medications work largely by reducing appetite
This product is not labeled, promoted, or approved for use in humans or animals, and is not a dietary supplement, medication, or cosmetic
Food and Drug Administration (FDA) for human consumption or medical use
It is not a drug, dietary supplement, food additive, cosmetic, or therapeutic agent, and must not be used in or on humans or animals
No compelling evidence supports routine b12 supplementation for people with normal levels starting semaglutide
